240 related articles for article (PubMed ID: 31861708)
1. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives.
Nikas IP; Themistocleous SC; Paschou SA; Tsamis KI; Ryu HS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861708
[TBL] [Abstract][Full Text] [Related]
2. Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis.
Duggan WP; O'Connell E; Prehn JHM; Burke JP
Mol Cell Biochem; 2022 Oct; 477(10):2451-2467. PubMed ID: 35583632
[TBL] [Abstract][Full Text] [Related]
3. Serine-arginine protein kinase 1 is associated with breast cancer progression and poor patient survival.
Li XH; Song JW; Liu JL; Wu S; Wang LS; Gong LY; Lin X
Med Oncol; 2014 Aug; 31(8):83. PubMed ID: 24961466
[TBL] [Abstract][Full Text] [Related]
4. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
[TBL] [Abstract][Full Text] [Related]
5. Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions.
Xu X; Wei Y; Wang S; Luo M; Zeng H
Oncotarget; 2017 Sep; 8(37):61944-61957. PubMed ID: 28977917
[TBL] [Abstract][Full Text] [Related]
6. The many faces of SRPK1.
Bullock N; Oltean S
J Pathol; 2017 Mar; 241(4):437-440. PubMed ID: 27859253
[TBL] [Abstract][Full Text] [Related]
7. SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells.
Wang C; Zhou Z; Subhramanyam CS; Cao Q; Heng ZSL; Liu W; Fu X; Hu Q
Commun Biol; 2020 May; 3(1):268. PubMed ID: 32461560
[TBL] [Abstract][Full Text] [Related]
8. Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.
Kurimchak AM; Kumar V; Herrera-Montávez C; Johnson KJ; Srivastava N; Davarajan K; Peri S; Cai KQ; Mantia-Smaldone GM; Duncan JS
Mol Cell Proteomics; 2020 Dec; 19(12):2068-2090. PubMed ID: 32994315
[TBL] [Abstract][Full Text] [Related]
9. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1.
Wagner KD; El Maï M; Ladomery M; Belali T; Leccia N; Michiels JF; Wagner N
Cells; 2019 Jan; 8(1):. PubMed ID: 30641926
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
Supradit K; Boonsri B; Duangdara J; Thitiphatphuvanon T; Suriyonplengsaeng C; Kangsamaksin T; Janvilisri T; Tohtong R; Yacqub-Usman K; Grabowska AM; Bates DO; Wongprasert K
Toxicol In Vitro; 2022 Aug; 82():105385. PubMed ID: 35568131
[TBL] [Abstract][Full Text] [Related]
11. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas.
Hayes GM; Carrigan PE; Miller LJ
Cancer Res; 2007 Mar; 67(5):2072-80. PubMed ID: 17332336
[TBL] [Abstract][Full Text] [Related]
12. SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases.
Oltean S; Gammons M; Hulse R; Hamdollah-Zadeh M; Mavrou A; Donaldson L; Salmon AH; Harper SJ; Ladomery MR; Bates DO
Biochem Soc Trans; 2012 Aug; 40(4):831-5. PubMed ID: 22817743
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
Dong Z; Chang X; Xie L; Wang Y; Hou Y
Bioengineered; 2022 Mar; 13(3):6100-6112. PubMed ID: 35192432
[TBL] [Abstract][Full Text] [Related]
14. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.
Schenk PW; Stoop H; Bokemeyer C; Mayer F; Stoter G; Oosterhuis JW; Wiemer E; Looijenga LH; Nooter K
Neoplasia; 2004; 6(4):297-301. PubMed ID: 15256051
[TBL] [Abstract][Full Text] [Related]
15. Serine-arginine protein kinase 1 is associated with hepatocellular carcinoma progression and poor patient survival.
Zhang J; Jiang H; Xia W; Jiang Y; Tan X; Liu P; Jia H; Yang X; Shen G
Tumour Biol; 2016 Jan; 37(1):283-90. PubMed ID: 26201897
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro.
Odunsi K; Mhawech-Fauceglia P; Andrews C; Beck A; Amuwo O; Lele S; Black JD; Huang RY
PLoS One; 2012; 7(12):e51030. PubMed ID: 23236423
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression.
Chandra A; Ananda H; Singh N; Qamar I
Aging (Albany NY); 2020 Dec; 13(1):163-180. PubMed ID: 33291073
[TBL] [Abstract][Full Text] [Related]
18. Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion.
Bullock N; Potts J; Simpkin AJ; Koupparis A; Harper SJ; Oxley J; Oltean S
J Clin Pathol; 2016 Feb; 69(2):171-5. PubMed ID: 26500332
[TBL] [Abstract][Full Text] [Related]
19. Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention.
Patel M; Sachidanandan M; Adnan M
Mol Biol Rep; 2019 Feb; 46(1):1487-1497. PubMed ID: 30535769
[TBL] [Abstract][Full Text] [Related]
20. Multi-posttranscriptional regulations lessen the repressive effect of SRPK1 on brown adipogenesis.
Lin JC
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):503-514. PubMed ID: 29474929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
